Evaluation and Treatment of Oral Soft Tissue Diseases
NCT00001601 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 999
Last updated 2008-03-04
Summary
This study offers evaluation and treatment of patients with diseases of the mouth or systemic diseases that involve the mouth. The protocol is not designed to test new treatments; rather, patients will receive current standard of care treatments. The purposes of the study are: 1) to allow NIDCR's Gene Therapy and Therapeutics Branch staff to gain more knowledge about oral soft tissue diseases and possibly identify new avenues of research in this area; and 2) to establish a pool of patients who may be eligible for new studies as they are developed. (Participants in this protocol will not be required to join a new study; the decision will be voluntary.)
Patients of any age with oral diseases or systemic diseases involving the mouth may be eligible for this study. Women of childbearing potential and women who are pregnant or breastfeeding will only have tests and procedures and receive medications that pose no greater than a minimal risk to the fetus.
Participants will have a comprehensive dental and medical examination, including a physical examination of the head and neck. Additional tests and procedures that may be required for diagnosis and to guide treatment include the following:
* Blood and urine tests - for routine laboratory studies, assessment of kidney and liver function, and detection of viruses, fungi, bacteria or parasites
* Electrocardiogram - to record the electrical activity of the heart
* Biopsies - to examine tissue under the microscope. The method and number of biopsies depends on the individual's specific condition and the tissue to be removed. For all biopsies a local anesthetic (lidocaine with or without epinephrine) is injected at the biopsy site. A punch biopsy uses a small sharp cookie-cutter instrument to remove a small (about 1/10- to 1/5-inch) piece of skin. An excisional biopsy uses a small surgical knife or scalpel to remove a piece of tissue, usually requiring some stitches to close the wound.
* Diagnostic imaging - X-rays, photographs, or other tests as needed for diagnosis
Treatments include tablets, injections and topically applied medications. All preparations are approved by the Food and Drug Administration and are commercially available. Patient follow-up may vary from one visit to intermittent visits over a number of years, depending on the patient's condition.
Conditions
- Aphthous Stomatitis
- Burning Mouth Syndrome
- Lichen Planus
- Mouth Disease
- Temporomandibular Joint Disorder
Interventions
- PROCEDURE
-
Electrocardiogram
- PROCEDURE
-
Biopsies
- PROCEDURE
-
Diagnostic imaging
Sponsors & Collaborators
-
National Institute of Dental and Craniofacial Research (NIDCR)
lead NIH
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1997-08-31
- Completion
- 2002-08-31
Countries
- United States
Study Locations
More Related Trials
-
The Functioning of Immune and Hormonal Systems in Patients With Sjogren's Syndrome and in Healthy Volunteers
NCT00001953 ·Status: COMPLETED
-
Burning Mouth Disorder (BMD) - A Neuropathic Pain Disorder
NCT00504387 ·Status: UNKNOWN
-
Salivary Evaluation in Healthy Volunteers
NCT00001390 ·Status: COMPLETED
-
Relationship Between Oral Lichen Planus and Autoimmune Thyroid Diseases
NCT05403216 ·Status: COMPLETED
-
Oral Health Needs Assessment of Sjogren s Syndrome and Salivary Gland Dysfunction Cohorts and Healthy Volunteers Evaluating Oral Health Disparities as Determinants of Oral Health in a High-Risk Population
NCT03327870 ·Status: COMPLETED
-
Clinical Research Core Dental Screening Protocol
NCT00090818 ·Status: COMPLETED
-
Potential of Transplanted Stem Cells to Mature Into Salivary Gland and Cheek Cells
NCT00023491 ·Status: COMPLETED
-
Dexamethasone Irrigation of the Parotid Glands in Primary Sjögren's Syndrome Subjects
NCT01316770 ·Status: TERMINATED ·Phase: PHASE2
-
Intraglandular Treatment With Adipose-derived Mesenchymal Stem Cells in Patients With Xerostomia Due to Sjögren's Disease
NCT06805448 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Effects of Denture-Related Stomatitis on Blood Pressure in Denture Wearers
NCT02166450 ·Status: UNKNOWN
-
HLA-DRB1 and HLA-DQB1 Genotyping for Autoantibody-positive and -Negative Patients With Atrophic Glossitis or Burning Mouth Syndrome
NCT01931293 ·Status: UNKNOWN ·Phase: NA
-
Autologous Oral Mucosa Transplantation for Limbal Stem Cell Deficiency
NCT03226015 ·Status: COMPLETED
-
Reducing Patient Memory Recall in the Burning Mouth Patient Population
NCT05819697 ·Status: RECRUITING
-
The Pathogenesis and Natural History of Sjogren's Disease
NCT01425892 ·Status: RECRUITING
-
Oral Manifestation in Patients With SARS-CoV2 Infection.
NCT04821986 ·Status: COMPLETED
-
Clinical Evaluation of Oral Rinse for Xerostomia
NCT04289051 ·Status: COMPLETED ·Phase: NA
-
CLINICAL EVALUATION OF THE EFFICACY OF AN INTRA ORAL SPRAY FOR PATIENTS WITH XEROSTOMIA
NCT04719091 ·Status: COMPLETED ·Phase: NA
-
BK Virus in Salivary Gland Disease: Treating the Potential Etiologic Agent
NCT02068846 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Treatments on Pain and Quality of Life in Individual With Burning Mouth Syndrome
NCT06040190 ·Status: RECRUITING ·Phase: PHASE4
-
The Effect of Chewing Gum, Exercises of the Tongue, Lip, Jaw on Salivation, Xerostomia, Dysphagia in Sjögren's Syndrome
NCT05680064 ·Status: COMPLETED ·Phase: NA
-
Study of Oral Bacteria in Patients With Dry Mouth
NCT00048685 ·Status: COMPLETED
-
Zinc Supplementation in Cirrhotic Patients
NCT02475928 ·Status: UNKNOWN ·Phase: NA
-
Endoscopic Treatment of Salivary Glands Affected by Sjögren's Syndrome
NCT02112019 ·Status: UNKNOWN ·Phase: NA
-
Impact of Alpha Lipoic Acid Efficacy in Burning Mouth Syndrome
NCT05729529 ·Status: UNKNOWN ·Phase: NA
-
Burning Mouth Syndrome: Effects of Occlusal Splint Therapy
NCT07344909 ·Status: NOT_YET_RECRUITING ·Phase: NA